These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 34392283

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Distinct Imaging Characteristics of Different Metastases From Primary Prostate Adenocarcinoma and Rectal Carcinoid Tumor on 18F-Fluciclovine and 68Ga-DOTATATE PET/CT.
    Bosserman AJ, Dai D, Lu Y.
    Clin Nucl Med; 2019 Jan; 44(1):83-84. PubMed ID: 30371597
    [Abstract] [Full Text] [Related]

  • 4. Supraclavicular and Axillary Lymphadenopathy Induced by COVID-19 Vaccination on 18F-Fluorthanatrace, 68Ga-DOTATATE, and 18F-Fluciclovine PET/CT.
    Surasi DSS, Lin L, Ravizzini G, Wong F.
    Clin Nucl Med; 2022 Feb 01; 47(2):195-196. PubMed ID: 34507331
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Mismatched Lesions on 18F-FDG PET and 18F-Fluciclovine PET Images in a Patient With Metastatic Prostate Small Cell Carcinoma.
    Gu J, Lu Y, Xu G.
    Clin Nucl Med; 2022 Mar 01; 47(3):255-257. PubMed ID: 34392287
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The Combined Interpretation of 68Ga-DOTATATE PET/CT and 18F-FDG PET/CT in Metastatic Gastroenteropancreatic Neuroendocrine Tumors: A Classification System With Prognostic Impact.
    Hayes AR, Furtado O'Mahony L, Quigley AM, Gnanasegaran G, Caplin ME, Navalkissoor S, Toumpanakis C.
    Clin Nucl Med; 2022 Jan 01; 47(1):26-35. PubMed ID: 34874347
    [Abstract] [Full Text] [Related]

  • 9. Integrated PET/MRI With 68Ga-DOTATATE and 18F-FDG in Pheochromocytomas and Paragangliomas: An Initial Study.
    Xu S, Pan Y, Zhou J, Ju H, Zhang Y.
    Clin Nucl Med; 2022 Apr 01; 47(4):299-304. PubMed ID: 35143455
    [Abstract] [Full Text] [Related]

  • 10. 68Ga-PSMA and 68Ga-FAPI-04 PET/CT Findings With 18F-FDG PET/CT in a Patient With Recurrent Prostate Cancer.
    Tatar G, Ergül N, Baloğlu MC, Arslan E, Çermik TF.
    Clin Nucl Med; 2023 Mar 01; 48(3):e135-e137. PubMed ID: 36723899
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. 18F-FDG, 68Ga-DOTATATE and 68Ga-PSMA Positive Metastatic Large Cell Neuroendocrine Prostate Tumor.
    Acar E, Kaya GÇ.
    Clin Nucl Med; 2019 Jan 01; 44(1):53-54. PubMed ID: 30325820
    [Abstract] [Full Text] [Related]

  • 13. Metastatic Poorly Differentiated Thyroid Cancer With Heterogeneous Distribution of 18F-FDG, 68Ga-DOTATATE, and 68Ga-PSMA on PET/CT.
    Civan C, Isik EG, Simsek DH.
    Clin Nucl Med; 2021 Apr 01; 46(4):e212-e213. PubMed ID: 33156050
    [Abstract] [Full Text] [Related]

  • 14. The lytic skeletal lesions: A rare presentation of carcinoma prostate on 18F-fluorodeoxyglucose positron emission tomography/computed tomography.
    Pande S, Mhatre N, Dhal I.
    J Cancer Res Ther; 2023 Jan 01; 19(Suppl 2):S939-S942. PubMed ID: 38384085
    [Abstract] [Full Text] [Related]

  • 15. Multicenter comparison of 18F-FDG and 68Ga-DOTA-peptide PET/CT for pulmonary carcinoid.
    Lococo F, Perotti G, Cardillo G, De Waure C, Filice A, Graziano P, Rossi G, Sgarbi G, Stefanelli A, Giordano A, Granone P, Rindi G, Versari A, Rufini V.
    Clin Nucl Med; 2015 Mar 01; 40(3):e183-9. PubMed ID: 25608152
    [Abstract] [Full Text] [Related]

  • 16. (18)F-FDG and (18)F-FLT PET/CT imaging in the characterization of mediastinal lymph nodes.
    Rayamajhi SJ, Mittal BR, Maturu VN, Agarwal R, Bal A, Dey P, Shukla J, Gupta D.
    Ann Nucl Med; 2016 Apr 01; 30(3):207-16. PubMed ID: 26661845
    [Abstract] [Full Text] [Related]

  • 17. Diagnostic performance of 18F-fluciclovine PET/CT for regional lymph node metastases in patients with primary prostate cancer: a multicenter phase II clinical trial.
    Suzuki H, Jinnouchi S, Kaji Y, Kishida T, Kinoshita H, Yamaguchi S, Tobe T, Okamura T, Kawakita M, Furukawa J, Otaka A, Kakehi Y.
    Jpn J Clin Oncol; 2019 Sep 01; 49(9):803-811. PubMed ID: 31095314
    [Abstract] [Full Text] [Related]

  • 18. Theranostic implications of molecular imaging phenotype of well-differentiated pulmonary carcinoid based on 68Ga-DOTATATE PET/CT and 18F-FDG PET/CT.
    Zidan L, Iravani A, Kong G, Akhurst T, Michael M, Hicks RJ.
    Eur J Nucl Med Mol Imaging; 2021 Jan 01; 48(1):204-216. PubMed ID: 32572559
    [Abstract] [Full Text] [Related]

  • 19. Differential 18F-FDG and 18F-Fluciclovine Uptake Pattern in a Patient With Poorly Differentiated Adenocarcinoma of the Lung and Prostate Cancer Biochemical Recurrence.
    Nguyen NC, Muthukrishnan A, Mountz JM.
    Clin Nucl Med; 2020 Jan 01; 45(1):e63-e64. PubMed ID: 31652158
    [Abstract] [Full Text] [Related]

  • 20. Comparison of (18F)FDG PET/CT and (68Ga)DOTATATE PET/CT imaging methods in terms of detection of histological subtype and related SUVmax values in patients with pulmonary carcinoid tumors.
    Komek H, Can C, Urakçi Z, Kepenek F.
    Nucl Med Commun; 2019 May 01; 40(5):517-524. PubMed ID: 30694875
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.